Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to announce the appointment of international Contract Research Organization (CRO), Lindus Health, as a key partner for its U.S. clinical trials program. Highlights CLEO has appointed U.S.-based Lindus Health to manage U.S. clinical trials for its…
Overview Cyclone Metals (ASX:CLE) is a listed exploration and development mining company focused on developing a world-class iron ore…
White Cliff Minerals Limited (White Cliff or the Company) is pleased to provide an update on planned work at…
Gold exchange-traded funds, or gold ETFs, have risen in popularity among investors who want precious metals exposure. ETFs are…
Interest in cobalt has increased in recent years due to its use in the lithium-ion batteries used to power…
Copper prices hit a nearly two year high this week, and according to analystsat investment bank Citigroup (NYSE:C) that’s…
Lancaster Resources Inc. (CSE:LCR | OTCQB:LANRF | FRA:6UF0) (‘ Lancaster’ or the ‘ Company ‘ ) a North American…
Description Far Northern Resources Limited (‘FNR’) was admitted to the Official List of ASX on Wednesday, 10 April 2024.…
At the start of the year, experts predicted nickel supply to maintain a surplus and the price would stay…